Business Services Industry
Citrix Names David Urbani Corporate Controller; Seasoned Executive From Maytag Specializes in Financial Practices Aimed at Increasing Shareholder Value
Business Wire, Feb 24, 2000
Business Editors/Technology Writers
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Feb. 24, 2000
Citrix(R) Systems, Inc. (Nasdaq:CTXS) today announced that David Urbani will become vice president, corporate controller for the company, effective March 6. Urbani comes to Citrix, a world leader in application server software and services, from Maytag Corporation, where he was vice president and treasurer.
"This year will prove to be a pivotal one for Citrix as we further fine-tune our financial operations to help us achieve our growth goals," said John Cunningham, Citrix senior vice president of finance and administration and CFO. "David Urbani brings the kind of experience we need to manage the financial operations of our business as we expand our presence as a global enterprise software provider."
"Citrix is a great company, and well positioned for even greater achievements," said Urbani. "Building on its existing leadership position in the application server software, the company is poised to be the infrastructure machine driving the very promising ASP market, and I am looking forward to contributing to Citrix's future success."
Urbani's financial experience includes treasury assignments at both Maytag and Air Products and Chemicals. At Maytag, he played a significant role in the overall financial restructuring of the company. At Air Products and Chemicals, he specialized in capital markets, risk management and financial analysis activities.
About Citrix
Citrix Systems, Inc. is a global leader in application server software and services that offer "Digital Independence(TM)" the ability to run any application on any device over any connection, wireless to Web. Citrix's solutions enable organizations of all types, from major enterprises to emerging Application Service Providers (ASPs), to reach more users, with more applications, in more locations - and achieve this with greater speed and predictability, and lower costs. Founded in 1989, Citrix today is one of the world's fastest-growing software companies, with more than 100,000 customers worldwide, including every one of the FORTUNE 100 firms. Its products, including MetaFrame(TM) software and Independent Computing Architecture (ICA(R)), a core application-server technology, have been widely adopted by the corporate mainstream to achieve key business goals. The firm, which markets its solutions through value-added resellers, system integrators and OEM licensees, is headquartered in Fort Lauderdale, Fla. Citrix is traded on the Nasdaq National Market under the symbol CTXS and was recently named to the Standard & Poor's 500 Index. For more information, please visit the Citrix Web site at http://www.citrix.com
For Citrix Investors
Forward-looking statements in this release are made pursuant to the safe harbor provisions of Section 21E of the Securities Exchange Act of 1934. Investors are cautioned that statements in this press release which are not strictly historical statements, including, without limitation, statements regarding current or future financial performance, management's plans and objectives for future operations, product plans and performance, management's assessment of market factors, as well as statements regarding the strategy and plans of the company and its strategic partners, constitute forward-looking statements which involve risks and uncertainties, including, without limitation, risks associated with the company's reliance upon its strategic relationships with Microsoft and other strategic partners, dependence upon broad-based acceptance of the company's ICA protocol, management of growth, market acceptance of new products or new versions of existing products, the possibility of undetected software errors, and dependence on proprietary technology, as well as risks of downturns in economic conditions generally, and in the software industry specifically, and risks associated with competition, competitive pricing pressures and year 2000 compliance efforts of the company and third parties on which the company is dependent. For a more detailed description of the risk factors associated with the company, please refer to the company's Annual Report or Form 10-K for the year ended December 31, 1998 and the Quarterly Report or Form 10-Q for the quarter ended September 30, 1999 on file with the Securities and Exchange Commission, and its Form 10-K for year ended December 31, 1999 to be filed shortly with the Commission.
Citrix(R), WinFrame(R) and ICA(R) are registered trademarks of Citrix Systems, Inc. MultiWin(TM), MetaFrame(TM) and NFuse(TM) are trademarks of Citrix Systems, Inc. for which there are pending applications for registration in the U.S. Patent and Trademark Office. UNIX(R) is a registered trademark of The Open Group in the U.S. and other countries. All other trademarks and registered trademarks are property of their respective owners.
- 5 Rules for Immediate Annuities
- Death in the Family: 12 Things to Do Now
- Dumbest Things You Do With Your Money
- 6 Online Networking Mistakes to Avoid
- 401(k) Mistakes to Avoid
- 5 Economic Scenarios to Keep You Up at Night
- The Real ‘Best Places to Retire’
- Best Credit Cards for You
- 12 Tough Questions to Ask Your Parents
- The Real ‘Best Colleges’
- Home Buyer Tax Credit: How to Cash In
- Why You Shouldn't Bash Cash
- 8 Phony 'Bargains' and Better Alternatives
- Danger: 3 Debit Card Scams to Avoid
- 6 Myths About Gas Mileage
- 29 Fees We Hate Most
- Quick and Easy Ways to Boost Returns
- Best Stocks to Buy Now
- Lower Your Taxes: 10 Moves to Make Now
- New Jobs: 8 Lessons from Real-Life Career Switchers
- The New Job Market: Who Wins and Who Loses?
- Health Care Reform's Public Option: Everything You Need to Know
- Volunteer Work When Unemployed: Should You Work for Free?
- Whose Recovery Is This?
- Long-Term-Care Insurance: 4 Biggest Risks to Avoid
Most Recent Business Articles
- Psyadon Pharmaceuticals, Inc. Announces Regulatory Milestones and the Initiation of a Clinical Trial of Ecopipam in Lesch-Nyhan Disease
- Emergence of “Femtomedicine” - New Frontier of Biomed Sciences - Reported at First Global Congress on Nano Medicine
- Research and Markets: Ethiopia Power Market Outlook to 2020
- Research and Markets: Orphan Drugs in Asia-Pacific: from Designation to Pricing, Funding & Market Access
- Research and Markets: Now You See It - TV Program Sponsorship & Product Placement in China
Most Recent Business Publications
Most Popular Business Articles
- 7 tips for effective listening: productive listening does not occur naturally. It requires hard work and practice - Back To Basics - effective listening is a crucial skill for internal auditors
- FHM Features Anna Benson, Baseball's Hottest Wife
- Building a DNA database: the federal government has just enacted two bills related to DNA. The first would drive the collection of DNA from all infants. The second would attempt to prevent the DNA that is collected from being misused
- America's most wanted j-o-b-s - 10 hottest employment opportunities
- Developmental sequence in small groups


